Loading publications…
The last 5 uploaded publications
A Prospective Natural-History Study of Coronary Atherosclerosis
Gregg W. Stone, Akiko Maehara, Alexandra J. Lansky, Bernard De Bruyne, Ecaterina Cristea, Gary S. Mintz, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Helen Parise, Barry Templin, Roseann White, Zhen Zhang, Patrick W. Serruys (2011). A Prospective Natural-History Study of Coronary Atherosclerosis. New England Journal of Medicine, 364(3), pp. 226-235, DOI: 10.1056/nejmoa1002358.
Article149 days agoA Prospective Natural-History Study of Coronary Atherosclerosis
Gregg W. Stone, Akiko Maehara, Alexandra J. Lansky, Bernard De Bruyne, Ecaterina Cristea, Gary S. Mintz, Roxana Mehran, John McPherson, Naim Farhat, Steven P. Marso, Helen Parise, Barry Templin, Roseann White, Zhen Zhang, Patrick W. Serruys (2011). A Prospective Natural-History Study of Coronary Atherosclerosis. New England Journal of Medicine, 364(3), pp. 226-235, DOI: 10.1056/nejmoa1002358.
Article146 days agoEvaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis
Patrick W. Serruys, Yoshinobu Onuma, Dariusz Dudek, Pieter C. Smits, Jacques Koolen, Bernard Chevalier, Bernard De Bruyne, Leif Thuesen, Dougal McClean, Robert‐Jan van Geuns, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel Hebert, Krishnankutty Sudhir, Héctor M. García‐García, John A. Ormiston (2011). Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis. Journal of the American College of Cardiology, 58(15), pp. 1578-1588, DOI: 10.1016/j.jacc.2011.05.050.
Article146 days agoPercutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial
Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys, Friedrich‐Wilhelm Mohr, Marie‐Claude Morice, Michael J. Mack, David R. Holmes, Nick Curzen, Piroze Davierwala, Thilo Noack, Milan Milojevic, Keith D. Dawkins, Bruno R. da Costa, Peter Jüni, Stuart J. Head, Filip Casselman, Bernard De Bruyne, Evald Høj Christiansen, Juan M. Ruiz-Nodar, Paul Vermeersch, Werner Schultz, Manel Sabaté, Giulio Guagliumi, Herko Grubitzsch, Karl Stangl, Olivier Darremont, Mohamed Bentala, Peter den Heijer, István Préda, Robert Stoler, Michael J. Mack, Tamás Szerafin, John K. Buckner, Myles S. Guber, Niels Verberkmoes, Ferdi Akca, Ted Feldman, Friedhelm Beyersdorf, Benny Drieghe, Keith G. Oldroyd, Geoff Berg, Anders Jeppsson, Kimberly Barber, Kevin Wolschleger, John Heiser, Pim van der Harst, Massimo A. Mariani, Hermann Reichenspurner, Christoffer Stark, Mika Laine, Paul C. Ho, John C. Chen, Richard Zelman, Phillip A. Horwitz, Andrzej Bochenek, Agata Krauze, Christina Grothusen, Dariusz Dudek, George P. Heyrich, Piroze Davierwala, Thilo Noack, Philippe Kolh, Victor Legrand, Pedro Coelho, Stephan Ensminger, Boris Nasseri, Richard Ingemansson, Göran Olivecrona, Javier Escaned, Reddy Guera, Sérgio Berti, Marie‐Claude Morice, Alaide Chieffo, M. Nicholas Burke, Michael Mooney, Alvise Spolaor, Christian Hagl, Michael Näbauer, Maarten J. Suttorp, Ronald A. Stine, Thomas McGarry, Scott Lucas, Knut Endresen, Andrew Taussig, Kevin Accola, Umberto Canosi, Iván Horváth, Louis Cannon, John D. Talbott, C W Akins, Robert S. Kramer, Michael Aschermann, William A. Killinger, Inga Narbute, David R. Holmes, Francesco Burzotta, Ad J.J.C. Bogers, Felix Zijlstra, Hélène Eltchaninoff, Jacques Berland (2019). Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. The Lancet, 394(10206), pp. 1325-1334, DOI: 10.1016/s0140-6736(19)31997-x.
Article146 days agoEvaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis
Patrick W. Serruys, Yoshinobu Onuma, John A. Ormiston, Bernard De Bruyne, Evelyn Regar, Dariusz Dudek, Leif Thuesen, Pieter C. Smits, Bernard Chevalier, Dougal McClean, Jacques Koolen, Stephan Windecker, Robert Whitbourn, Ian T. Meredith, Cécile Dorange, Susan Veldhof, Karine Miquel‐Hébert, Richard Rapoza, Héctor M. García‐García (2010). Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis. Circulation, 122(22), pp. 2301-2312, DOI: 10.1161/circulationaha.110.970772.
Article146 days ago